GIP与GLP-1双受体激动剂
Identity, purity and main-peak area are checked by reversed-phase HPLC against an in-house reference standard for this sequence. The chromatogram you see on the certificate of analysis is generated at this exact bench, by the analysts who release the batch.
When a sequence moves from milligram research lots to multi-gram research supply, the same chemistry is transferred onto jacketed stainless reactors. Temperature, agitation and reagent equivalents are logged in real time so that the larger batch matches the analytical fingerprint of the small one.
替尔泊肽是首个上市的GIP/GLP-1双重激动剂，39个氨基酸的合成多肽，同时激活两条肠促胰素通路。
GIP受体的协同激活增强了胰岛素分泌、改善脂质代谢并调节脂肪组织功能，与GLP-1效应叠加，产生更显著的代谢与体重影响。
用于代谢综合征、肥胖与2型糖尿病的研究模型，同时被探索用于NASH与心血管代谢风险的复合干预。
39氨基酸修饰多肽，C20双酸脂肪侧链锚定白蛋白结合域，每周一次药代特性。
